Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis

Keri Seymour1, Jeffrey Stein1, Xuan Han1

  • 1Division of Vascular Surgery and Endovascular Services, SUNY Upstate Medical University, Syracuse, NY, USA Department of Veterans Affairs, VA Healthcare Network Upstate New York at Syracuse, Syracuse, NY, USA.

Insights

Short-term statin use inhibits vascular smooth muscle cell migration induced by thrombospondin 1. However, nitric oxide donors can reverse this statin effect, indicating potential for combination therapies.

Area of Science:

  • Cardiovascular Biology
  • Pharmacology
  • Cellular Biology

Background:

  • Thrombospondin 1 (TSP-1) is implicated in vascular smooth muscle cell (VSMC) migration and intimal hyperplasia.
  • Statins and nitric oxide (NO) donors are known to reduce intimal hyperplasia.
  • Previous research indicated that statins and NO donors inhibit TSP-1-induced VSMC chemotaxis.

Purpose of the Study:

  • To investigate if short-term statin pretreatment inhibits TSP-1-induced VSMC chemotaxis.
  • To determine if NO donors enhance statin inhibition of TSP-1- or platelet-derived growth factor (PDGF)-induced VSMC chemotaxis.

Main Methods:

  • Examined the effects of long-term (20 hours) versus short-term (20 minutes) pravastatin on TSP-1-induced VSMC chemotaxis.
  • Assessed the impact of diethylenetriamine NONOate (DETA/NO) or S-nitroso-N-acetylpenicillamine (SNAP) in combination with pravastatin.
  • Compared TSP-1 with PDGF as chemoattractants in the presence of DETA/NO and pravastatin.

Main Results:

  • Both long-term and short-term pravastatin inhibited TSP-1-induced VSMC chemotaxis.
  • DETA/NO and SNAP diminished the inhibitory effect of statins on TSP-1-induced chemotaxis.
  • PDGF and TSP-1 exhibited opposing effects when used with DETA/NO and pravastatin.

Conclusions:

  • Short-term statin pretreatment demonstrates a pleiotropic effect by inhibiting TSP-1-induced VSMC chemotaxis.
  • High-dose NO reversed statin-mediated inhibition of TSP-1-induced chemotaxis.
  • The interplay between NO and statins suggests combination therapies warrant further investigation for cardiovascular applications.
Abstract

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
4.9K